Electrophysiological Properties of the Pulmonary Veins

This study has been completed.
Sponsor:
Information provided by:
Universitätsklinikum Hamburg-Eppendorf
ClinicalTrials.gov Identifier:
NCT00530608
First received: September 13, 2007
Last updated: February 9, 2010
Last verified: June 2008
  Purpose

The pulmonary veins are the predominant sources of AF induction and maintenance. This study aims to assess the electrophysiological properties of the pulmonary veins and their relation to AF in humans.


Condition
Electrophysiology of Pulmonary Veins

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Electrophysiological Properties of the Pulmonary Veins

Further study details as provided by Universitätsklinikum Hamburg-Eppendorf:

Enrollment: 35
Study Start Date: June 2006
Study Completion Date: November 2007
  Eligibility

Ages Eligible for Study:   18 Years to 75 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

First review of the data base with respect to study outcome was performed after 35 enrolled patients. As a result, the results were already significant and the study was stopped prematurely.

Criteria

Inclusion Criteria:

  • Age > 18 years
  • No antiarrhythmic drug treatment
  • Indication for an electrophysiological study

Exclusion Criteria:

  • Structural heart diseases
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00530608

Locations
Germany
University Hospital Eppendorf, Heart Center, Department of Cardiology
Hamburg, Germany, 20246
Sponsors and Collaborators
Universitätsklinikum Hamburg-Eppendorf
Investigators
Principal Investigator: Thomas Rostock, MD University Hospital Eppendorf, Heart Center, Department of Cardiology
  More Information

No publications provided by Universitätsklinikum Hamburg-Eppendorf

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Dr. Thomas Rostock, Universitätsklinikum Hamburg-Eppendorf
ClinicalTrials.gov Identifier: NCT00530608     History of Changes
Other Study ID Numbers: UHZ/2007/1
Study First Received: September 13, 2007
Last Updated: February 9, 2010
Health Authority: Germany: Hamburg Ethical Committee

ClinicalTrials.gov processed this record on July 24, 2014